English
This article is from Indian Journal of Endocrinology and Metabolism , volume 16 . Abstract It is obligatory for all adult Muslims to observe fast during the holy month of Ramadan, but sick individuals including those with diabetes mellitus are exempted from the duty of fasting. Specific medical advice must be provided to individual patients concerning the potential risks they must accept if they decide to fast. Any alteration in medications deemed necessary to provide an effective and safe antidiabetic regimen should be instituted well before the start of Ramadan. Diet-controlled patients and those well controlled on insulin sensitizers have low risk of hypoglycemia and may safely fast with some modification in the timing of the doses. Newer generation sulfonylureas (gliclazide MR and glimepiride) have reasonable safety profile during Ramadan fasting and are economical options for a large number of diabetics worldwide, especially in the developing countries; older, long acting sulfonylureas like glibenclamide and chlorpropamide should be avoided during fasting. Oral DPP-IV inhibitors are important substitutes to sulfonylureas for patients with diabetes mellitus during fasting owing
Sign in with your free account to read, download EPUBs or listen.
Ebook · Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan. · Bashir, Mir Iftikhar, Pathan, Md Faruque, Raza, Syed Abbas, Ahmad, Jamal, Khan, A. K. Azad, Ishtiaq, Osama, Sahay, Rakesh K., Sheikh, Aisha · Internet Archive